Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortis (FTS) Common Equity (2016 - 2026)

Fortis filings provide 12 years of Common Equity readings, the most recent being $19.3 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 5.8% to $19.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $19.3 billion, a 5.8% increase, with the full-year FY2025 number at $18.6 billion, changed 0.23% from a year prior.
  • Common Equity hit $19.3 billion in Q1 2026 for Fortis, up from $18.6 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $19.3 billion in Q1 2026 to a low of $16.6 billion in Q1 2022.
  • Median Common Equity over the past 5 years was $17.8 billion (2024), compared with a mean of $17.8 billion.
  • Biggest five-year swings in Common Equity: increased 9.97% in 2022 and later decreased 0.19% in 2023.
  • Fortis' Common Equity stood at $16.8 billion in 2022, then grew by 1.84% to $17.1 billion in 2023, then grew by 7.99% to $18.5 billion in 2024, then grew by 0.23% to $18.6 billion in 2025, then increased by 4.12% to $19.3 billion in 2026.
  • The last three reported values for Common Equity were $19.3 billion (Q1 2026), $18.6 billion (Q4 2025), and $19.1 billion (Q3 2025) per Business Quant data.